1. Home
  2. BAOS vs ALBT Comparison

BAOS vs ALBT Comparison

Compare BAOS & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BAOS

Baosheng Media Group Holdings

HOLD

Current Price

$2.64

Market Cap

4.0M

ML Signal

HOLD

Logo Avalon GloboCare Corp.

ALBT

Avalon GloboCare Corp.

HOLD

Current Price

$0.28

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAOS
ALBT
Founded
2018
2014
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
3.3M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
BAOS
ALBT
Price
$2.64
$0.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
78.3K
431.4K
Earning Date
05-08-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.18
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.98
$0.21
52 Week High
$5.40
$4.74

Technical Indicators

Market Signals
Indicator
BAOS
ALBT
Relative Strength Index (RSI) 45.53 36.48
Support Level $2.45 $0.21
Resistance Level $2.82 $0.39
Average True Range (ATR) 0.19 0.03
MACD -0.02 -0.00
Stochastic Oscillator 21.31 6.26

Price Performance

Historical Comparison
BAOS
ALBT

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd is a China-based online marketing solution provider. The company provides internet marketing, short-video and V-log marketing, content production and operation, e-commerce marketing, data platform services, and AI technology-related services. It also offers customized marketing solutions and channel marketing services through partnerships with internet platforms such as Tencent, Alibaba, ByteDance, and Kuaishou.

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Share on Social Networks: